Polypeptide with high calcium chelating activity prepared from cod bones
By isolating the high-calcium-chelating polypeptide GGYDEY from cod bones, the problem of low cod bone utilization has been solved, realizing the high-value utilization of cod bone resources, improving the bioavailability of calcium in the human body and the economic benefits of the aquatic product processing industry.
Patent Information
- Application Number
- CN202411387834.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-07
- Publication Date
- 2024-11-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The utilization rate of cod bones in existing technologies is low, leading to resource waste and environmental pollution. Furthermore, the activity of cod bone calcium chelate peptides is low, making it difficult to effectively improve the economic benefits of the aquatic product processing industry.
Crude protein was extracted from cod bones, and the polypeptide GGYDEY with high calcium chelating activity was separated by enzymatic hydrolysis, hydroxyapatite affinity chromatography, Sephadex G25 gel filtration chromatography, and C18 reversed-phase high-performance liquid chromatography. Under specific conditions, it chelated with calcium ions to form a peptide-calcium chelate.
A cod bone peptide with a calcium chelation capacity of 8.39±0.40μg/mg was prepared, which improved the bioavailability of calcium in the human body, solved the problem of high-value utilization of cod bone resources, and enhanced the economic benefits of the aquatic product processing industry.
Smart Images

Figure CN118978570A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of functional biological product preparation, and specifically relates to a polypeptide with high calcium chelating activity prepared from cod fish bones. Background Art
[0002] Calcium chelating peptides can combine with calcium ions to form peptide calcium chelates. The chelates can competitively bind to calcium ions with anti-nutritional factors such as phosphate, phytic acid, and oxalic acid in the intestine, preventing calcium ions from precipitating in the gastrointestinal tract and enhancing their bioavailability. At the same time, the chelates have low gastrointestinal irritation, no side effects, and have the advantages of peptide and calcium supplementation, and can be used as an ingredient in the development of functional foods.
[0003] At present, a variety of peptides with calcium chelating ability have been found from animal protein, plant protein, algae protein and aquatic protein. For example, the calcium chelating peptide DEEENDQVK was obtained after trypsin hydrolysis of egg yolk phospholipids, and its calcium binding capacity reached 151.1 mg / g. The calcium binding peptide prepared by papain and flavor enzyme composite hydrolysis of flat-rudder bonito has a calcium chelating activity of 76.8±4.5 mg / g. The calcium chelating peptide FPPDVA purified from peanut protein by combining Sephadex G25 and G15 has a calcium binding capacity of 15.67±0.39 mg / g. The calcium chelating peptide KGDPGLSPGK purified from cod bone gelatin by hydroxyapatite and reversed-phase high-performance liquid chromatography has a calcium binding capacity of 2.53±0.12μg / mg.
[0004] During the processing of cod, waste such as fish skin, fish head, and fish bones are produced, of which fish bones account for 15% of the total weight of cod. The utilization rate of fish bones is extremely low during the processing process. Only a small part is processed into fish meal or pet feed, and most of them are directly discarded. The low proportion of deep processing has caused resource waste and environmental pollution. The rich content of collagen and calcium in cod bones (40-50% of the dry matter of fish bones is collagen, and 20-25% is calcium) is a high-quality resource for the development of fish bone calcium chelate peptides. After the fish bone byproducts are developed into calcium chelate peptides, a new calcium supplement product, the value can be increased by dozens to hundreds of times, which will greatly improve the economic benefits of my country's aquatic product processing industry. However, there are currently few reports on cod bone calcium chelate peptides, and the activity is low. Summary of the invention
[0005] The purpose of the present invention is to provide a polypeptide with high calcium chelating activity prepared from cod bones. The cod bone peptide provided by the present invention has good calcium chelating activity, and its calcium chelating capacity reaches 8.39±0.40μg / mg; peptide calcium chelates prepared with this peptide can be used for the development of calcium supplement preparations to improve the bioavailability of calcium in the human body.
[0006] The present invention firstly provides a polypeptide (F21-2) with high calcium chelating activity prepared from cod fish bones, and the amino acid sequence thereof is GGYDEY (SEQ ID NO: 1).
[0007] The polypeptide provided by the present invention is prepared by the following method:
[0008] The crude protein is extracted from cod bones and separated by enzymatic hydrolysis, hydroxyapatite affinity chromatography, Sephadex G25 gel filtration chromatography and C18 reverse phase high performance liquid chromatography.
[0009] The present invention also provides a use of the polypeptide, which is use in preparing peptide calcium chelates.
[0010] In another aspect, the present invention also provides a peptide calcium chelate, which is prepared using the above-mentioned polypeptide as a chelating peptide;
[0011] The peptide calcium chelate, one preparation method of which is Ca 2+ The peptide calcium chelate prepared by chelating at room temperature for 0.5h under the conditions of 0.5mM concentration, 1.5g / L polypeptide concentration and pH 7.0 has a high chelation rate and can prevent the precipitation of calcium ions in the gastrointestinal tract, thereby promoting calcium absorption. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 The hydroxyapatite affinity chromatography diagram is shown in FIG. 1 , wherein (a) is the hydroxyapatite affinity chromatography elution spectrum; and (b) is the calcium chelating ability determination result of each elution component.
[0013] Figure 2 The figure is a Sephadex G25 gel filtration chromatogram, wherein (a) is the Sephadex G25 gel filtration chromatogram elution profile; and (b) is the calcium chelating capacity determination result of each elution component.
[0014] Figure 3 The elution spectrum of C18 reversed-phase high performance liquid chromatography is shown in FIG. 1 , wherein (a) is the elution spectrum of C18 reversed-phase high performance liquid chromatography; and (b) is the determination result of the calcium chelating ability of each elution component.
[0015] Figure 4 The diagrams are the results of mass spectrometry identification, where (a) is the extracted ion current diagram, (b) is the primary mass spectrum diagram, (c) is the secondary mass spectrum diagram, and (d) is the structure diagram.
[0016] Figure 5 The physical and chemical properties analysis of GGYDEY (F21-2) and GGYDEY-Ca (F21-2-Ca), where (a) is the UV-visible spectrum, (b) is the Fourier transform infrared spectrum, (c) is the circular dichroism spectrum, and (d) is the Raman spectrum.
[0017] Figure 6 Cod bone peptide with high calcium chelating activity 2+ Optimization diagram of chelation conditions. DETAILED DESCRIPTION
[0018] The invention identifies a novel cod bone-derived calcium chelating peptide GGYDEY through hydroxyapatite affinity chromatography, Sephadex G25 gel filtration chromatography and C18 reverse phase high performance liquid chromatography in combination with Q-Orbitrap, and the calcium chelating activity of the peptide reaches 8.39±0.40 μg / mg.
[0019] In the following examples, the method for determining calcium chelating activity is as follows:
[0020] 3 mg of sample was dissolved in 2 mL of 5 mmol / L CaCl2 and incubated at 37°C for 20 min. 4 mL of 20 mmol / L sodium phosphate buffer (pH 7.5) was added to the reaction system and incubated at 37°C for 30 min. The solution was centrifuged at 8000 rpm / min for 20 min to remove calcium phosphate precipitate. After the supernatant was filtered through a 0.22 μm filter, 2 mL was taken and digested with 10 mL of nitric acid. The calcium content was determined according to GB 5009.92-2016 (atomic absorption method). A blank control group without adding polypeptide was set up. The calculation formula of calcium chelation activity is as follows:
[0021]
[0022] Wherein, Cs is the calcium content in the supernatant of each sample group, μg; Cc is the calcium content in the supernatant of the control group, μg; Ms is the sample mass, mg.
[0023] In the following embodiments, the UV-visible spectrum is measured as follows:
[0024] The sample was dissolved in deionized water to a concentration of 1 mg / mL, and the UV-visible spectrum of the sample was measured with a UV-visible spectrophotometer in a wavelength range of 190 to 350 nm, and deionized water was used for blank correction.
[0025] In the following embodiments, the determination method of Fourier transform infrared spectroscopy is as follows:
[0026] After the sample was repeatedly freeze-dried to remove moisture, 1-2 mg was taken and placed in an agate mortar with an appropriate amount of potassium bromide (KBr) dried to constant weight, ground and mixed, and then pressed into tablets. The infrared spectrum was measured using a Nicolet-iS10 Fourier transform infrared spectrometer with a scanning range of 4000-500 cm -1 , scanning resolution is 2cm -1The number of scans was 64. KBr background was subtracted from all samples. To reduce the influence of moisture in the air, all operations were performed under an infrared lamp.
[0027] In the following embodiments, the circular dichroism spectrum is measured as follows:
[0028] The samples were dissolved in deionized water to 0.1 mg / mL. The circular dichroism spectra of the peptide components and peptide calcium chelates were collected using Jasco-1500. The scanning range was set to 180-260 nm, the scanning speed was 100 nm / min, and the resolution was 0.5 nm. Each sample was calibrated using deionized water as the background.
[0029] In the following embodiments, the Raman spectrum is measured as follows:
[0030] Spread the sample powder on a glass slide and place it on the sample measuring platform. Focus the sample and record the excitation wavelength of 532nm at 200cm -1 Up to 2000cm -1 Raman spectra in the range.
[0031] The present invention is described in detail below in conjunction with specific embodiments and drawings.
[0032] Example 1: Preparation of cod bone peptide with high calcium chelating activity
[0033] (1) Preparation of cod bone hydrolysates (PBPs)
[0034] The fish bones were softened at 121°C for 50 min and then wet-ground. Distilled water was added at a ratio of 1:4 (w / v) and fully extracted at 80°C for 4 h to obtain cod bone crude protein. The crude protein concentration was adjusted to 100 g / L. Papain with a substrate protein content of 1% was added and hydrolyzed at pH = 6.5 and 55°C for 4 h. The enzyme was boiled for 15 min to inactivate the enzyme. After centrifugation at 8000 rpm / min for 15 min, the supernatant was concentrated and freeze-dried to obtain cod bone hydrolysate (PBPs).
[0035] (2) Hydroxyapatite affinity chromatography separation of cod bone peptide with high calcium chelating activity:
[0036] ① Solution preparation: Buffer A (containing 5mmol / L phosphate, 100mmol / L NaCl, pH 6.7): weigh 0.441g NaH2PO4·2H2O, 0.779g Na2HPO4·12H2O, and 5.844g NaCl, dissolve them in a small amount of distilled water and make up to 1L.
[0037] 60mmol / L phosphate eluent: Accurately weigh 5.288g NaH2PO4·2H2O, 9.347g Na2HPO4·12H2O, and 5.844g NaCl, dissolve them in a small amount of distilled water and make up to 1L.
[0038] 120mmol / L phosphate eluent: Accurately weigh 10.577g NaH2PO4·2H2O, 18.695g Na2HPO4·12H2O, and 5.844g NaCl, dissolve them in a small amount of distilled water and make up to 1L.
[0039] 180mmol / L phosphate eluent: weigh 15.866g NaH2PO4·2H2O, 28.042g Na2HPO4·12H2O, and 5.844g NaCl, dissolve them in a small amount of distilled water and make up to 1L.
[0040] Buffer C (containing 0.5 mol / L phosphate, pH 8.0): weigh 4.134 g of NaH2PO4·2H2O and 169.579 g of Na2HPO4·12H2O, dissolve them in a small amount of distilled water and make up to 1 L.
[0041] ② Hydroxyapatite affinity chromatography: Wash the hydroxyapatite filler with Buffer C and centrifuge (1000rpm / min, 5min) 5 times to fully activate the filler. The hydroxyapatite chromatography column is balanced with Buffer A for 2h. PBPs dissolved in Buffer A are added to the chromatography column. After the sample is combined with the hydroxyapatite chromatography medium for 3h, it is eluted with Buffer A for 20min. After all the components without affinity flow out, 60, 120, and 180mmol / L phosphate are used for elution in turn. The flow rate is 1mL / min. The elution peak is collected every 2min, the absorbance value is measured at 220nm, and the elution spectrum is drawn.
[0042] like Figure 1 As shown in the figure, the calcium chelating activity of the components eluted with 120mmol / L and 180mmol / L phosphate was similar, 4.30±0.52μg / mg and 4.18±0.80μg / mg, respectively. The calcium chelating activity of the components eluted with 60mmol / L phosphate was 1.38±0.70μg / mg. The calcium chelating activity of the components eluted with Buffer A was 0.65±0.16μg / mg. It can be seen that hydroxyapatite can elute most of the cod bone peptides without calcium chelating activity, and achieve targeted capture of peptides with high calcium chelating activity.
[0043] (3) Sephadex G25 gel filtration chromatography:
[0044] The high-activity fraction prepared by hydroxyapatite affinity chromatography was further separated and purified by Sephadex G25 gel column chromatography (1.6 cm × 80 cm). The affinity chromatography fraction was lyophilized and dissolved in ultrapure water to 10 mg / mL, and the ultrapure water elution flow rate was set to 0.5 mL / min. One tube was collected every 5 minutes, and the absorbance was detected at 220 nm after dilution, and the elution spectrum was drawn. Each peak was collected, and the calcium chelation capacity of each component was determined.
[0045] like Figure 2 As shown in a, the high-activity fraction prepared by hydroxyapatite affinity chromatography was separated into three peaks by G25 gel filtration chromatography according to the different molecular weights, and was named F1, F2 and F3 according to the peak elution time. The calcium chelating activity of the three fractions was measured, and the results were shown in Figure 2 As shown in b, the calcium chelating ability of F2 and F3 was significantly improved, especially the calcium chelating activity of F3 reached 7.26±1.31 μg / mg, which was increased by 71.23% compared with the high-activity fraction prepared by hydroxyapatite affinity chromatography.
[0046] (4) Reversed-phase high performance liquid chromatography
[0047] Use reverse phase HPLC Zorbax SB-C18 semi-preparative column (9.4×250mm) for further separation and purification. The elution parameters are as follows: mobile phase A is acetonitrile and mobile phase B is ultrapure water. The gradient elution program is 0-5min (15% A), 5-25min (15% A-70% A), 25-35min (75% A), 35-40min (75% A-15% A). The flow rate is 1.0mL / min, the column temperature is 35°C, the detection wavelength is 220nm, and the elution time is 40min. Collect each component to determine the calcium chelating activity. Figure 3 As shown in a, the high-activity fraction obtained by G25 gel filtration chromatography was further divided into five peaks, named F21, F22, F23, F34 and F25. Figure 3 b is the calcium chelating activity of each component eluted by RP-HPLC. The highest calcium chelating capacity of F21 and F22 is 7.52±1.06μg / mg and 7.94±1.56μg / mg, respectively.
[0048] (5) Sequence Identification of Cod Bone Peptide with High Calcium Chelating Activity
[0049] UHPLC-Q-Orbitrap was used to identify the amino acid sequence of the calcium chelating peptide, and the chromatographic column used was Agilent Advance Bio Peptide Map C18 column. UHPLC parameters: mobile phase A: 0.1% formic acid-water; mobile phase B: 0.1% formic acid-acetonitrile, flow rate: 0.15 mL / min, injection volume: 10 μL. Column temperature: 40°C, gradient elution program 0-20 min, 2%-25% B; 20-30 min, 25-45% B; 30-35 min, 45%-85% B; 35-40 min, 85% B; 40-42 min, 85-2% B; 42-52 min, 2% B. Scanning range: 100-1200 m / z, electrospray mode: electrospray positive ion, electrospray voltage 3600 v. The peptide segments in the liquid phase components were identified as follows. Figure 4 As shown, a polypeptide with a polypeptide sequence of GGYDEY was obtained.
[0050] Example 2: Synthesis of GGYDEY and verification of chelating activity
[0051] The identified peptide GGYDEY was produced by solid phase peptide synthesis. The calcium binding capacity of GGYDEY prepared by solid phase synthesis was verified, and its calcium chelation capacity was 8.39±0.40mg / g. 2+ GGYDEY-Ca was prepared by chelation at room temperature for 0.5 h under the conditions of 0.5 mM concentration, 1.5 g / L GGYDEY concentration and pH 7.0. This calcium chelate can compete with anti-nutritional factors such as oxalic acid, phytic acid and tannins to bind Ca in the gastrointestinal tract. 2+ , so that Ca 2+ It can remain dissolved in the small intestine and then be absorbed and utilized by the small intestinal epithelial cells.
[0052] Example 3: Physical and Chemical Properties of GGYDEY and GGYDEY-Ca
[0053] like Figure 5 As shown in a, there are significant differences in the UV-visible spectra of GGYDEY and GGYDEY-Ca. The λmax of GGYDEY is 193nm, which is caused by the n→π* transition of -C=O in specific carbonyl, carboxyl and amide bonds in the polypeptide. 2+ After chelation, the λmax of GGYDEY-Ca shifted to 194 nm, and the absorbance of the chelate increased.
[0054] The Fourier transform infrared spectra of GGYDEY and GGYDEY-Ca are as follows Figure 5 As shown in b, the infrared spectrum of GGYDEY-Ca showed obvious changes compared with that of GGYDEY, which indicated that some amino acid groups were involved in the Ca2+ Chelated. GGYDEY at 3296.96cm -1 The peak at is the characteristic peak of the amide A band, which is caused by the stretching vibration of NH. However, this peak shifts to 3294.52 cm in GGYDEY-Ca. -1 , and the strength is significantly enhanced. GGYDEY at 1675.15cm -1 The absorption peak at is the characteristic peak of the amide I band, which is generated by the -C=O- stretching vibration. This absorption peak moves to 1655.39 cm in GGYDEY-Ca. -1 , and the intensity is significantly weakened, which indicates that the carboxyl group in GGYDEY participates in the Ca 2+ Chelation. The oxygen atoms of the carboxyl and carbonyl side chain hydroxyl groups participate in the chelation of GGYDEY and Ca 2+ Chelation.
[0055] The CD spectra of GGYDEY and GGYDEY-Ca are as follows Figure 5 c. The results show that Ca 2+ After chelation, the secondary structure of each peptide segment undergoes different changes, and random coil is the main secondary structure of GGYDEY and GGYDEY-Ca. 2+ After chelation Ca 2+ After chelation, the random coil content of GY increased from 38.3% to 46.7%, the β-sheet decreased from 24.9% to 18.0%, and the β-turn increased from 36.8% to 35.3%.
[0056] Raman spectroscopy is a non-destructive analytical technique commonly used in modern research to obtain sample information by measuring the frequency change of scattered light after the incident light interacts with the sample based on the Raman scattering effect. In biochemistry, it can be used to study the complex structure of macromolecules such as proteins or peptides. For example, important information about protein folding can be inferred by analyzing the peaks related to peptide bonds (usually amide I and II) in the Raman spectrum. The Raman spectra of GGYDEY and GGYDEY-Ca are shown in Figure 1. Figure 5 d, the results showed that after calcium chelation, the amide I band of GGYDEY shifted from 1677.15 cm -1 Transfer to 1669.22cm -1 , indicating that C=O may be involved in the Ca 2+ Chelation, 724.25cm -1 The amide IV / V band at 597.79 cm -1 The characteristic absorption peak of the amide VI band at 1671.87 cm disappeared, indicating that the peptide bond and the NH group of the amino acid side chain were affected by calcium chelation. -1 The intensity of the characteristic peak of the amide I band of 2+Chelation; 1236.43cm -1 The characteristic peak of the amide III band at 1256.01 cm -1 , 913.27cm -1 The characteristic peak caused by C-C bond stretching shifted to 915.13 cm -1 , 712.29cm -1 The intensity of the amide IV / V characteristic peak at 594.75 cm -1 The characteristic absorption peak of the amide VI band at the position disappears, indicating that calcium chelation causes the secondary structure of the polypeptide to change, causing changes in the O=CN bond, NH bond and C=O bond, which in turn leads to changes in its Raman absorption peak.
[0057] Example 4: Optimization of chelation conditions for cod bone peptide with high calcium chelation activity
[0058] like Figure 6 As shown in the figure, the calcium binding capacity of calcium chelating peptide increases first and then stabilizes with the increase of chelating pH, reaching 4.00±0.51μg / mg at pH 7.0. 2+ The calcium binding capacity of calcium chelating peptides gradually increases with the increase of Ca concentration. 2+ The calcium chelation capacity was similar at 0.5mmol / L and 0.6mmol / L, 3.74±0.63μg / mg and 4.05±0.22μg / mg, respectively. 2+ When the concentration is constant, the calcium chelation ability of the calcium chelating peptide increases first and then stabilizes with the increase of the peptide concentration. When the peptide concentration is 1.5g / L, the calcium chelation ability is 3.19±1.22μg / mg. Thereafter, as the peptide concentration increases, the calcium chelation activity does not change significantly. Through the above research, it can be determined that the optimal conditions for peptide calcium chelation are calcium ion concentration of 0.5mmol / L, peptide concentration of 1.5g / L, pH=7.0, and chelation at room temperature for 0.5h.
[0059] In summary, the present invention uses cod bones as raw materials to separate and prepare high calcium chelating active cod bone peptides, which is of great significance for the development of calcium supplement preparations and provides a new idea for the high-value utilization of cod bones.
Claims
1. A polypeptide with high calcium chelating activity prepared from cod bones, characterized in that: The amino acid sequence of the polypeptide is SEQ ID NO:
1.
2. The polypeptide according to claim 1, characterized in that The polypeptide is obtained by extracting crude protein from cod bones and separating it through enzymatic hydrolysis, hydroxyapatite affinity chromatography, Sephadex G25 gel filtration chromatography and C18 reverse phase high performance liquid chromatography.
3. Use of the polypeptide according to claim 1 in the preparation of peptide calcium chelates.
4. A peptide calcium chelate, characterized in that: The peptide calcium chelate is prepared by using the polypeptide according to claim 1 as a chelating peptide.
5. The peptide calcium chelate according to claim 4, characterized in that The preparation method of the peptide calcium chelate, wherein Ca 2+ The concentration was 0.5 mM, the polypeptide concentration was 1.5 g / L, and the pH was 7.0, and the chelation was carried out at room temperature for 0.5 h.
6. Use of the peptide calcium chelate according to claim 5 in the preparation of calcium supplement products.
7. A calcium supplement product, characterized in that: The calcium supplement product contains the peptide calcium chelate according to claim 5.
Citation Information
Patent Citations
Method for preparing metal chelating peptide by protein enzymolysis
CN103880942A
Tilapia skin antioxidant peptide and preparation method thereof
CN114805482A
Iron-chelated collagen peptide for promoting iron absorption as well as preparation method and application of iron-chelated collagen peptide
CN117024573A
